Pharma's Almanac: Nice Insight's Content Community

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Biopharma

Sep 27, 2024

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Fab Biopharma’s Reiner Getz, Ph.D., and Gardiner Smith, J.D. discuss how the company aims to revolutionize the treatment of complex and often life-threatening autoimmune diseases like Sjögren’s disease and lupus with its groundbreaking soluble bispecific receptor therapies

Optimized Residual dsRNA Detection for mRNA Therapeutics

RNA

Sep 30, 2024

Optimized Residual dsRNA Detection for mRNA Therapeutics

A team of experts from Samsung Biologics discusses the company’s development of a superior ELISA-based method for dsRNA detection that ensures greater accuracy and reliability.

Bioassays

Sep 30, 2024

Developing a Toolbox of Functional Bioassays for Optimizing ADCC

Tanvex CDMO’s Anke Hartung, Ph.D., discusses her team’s development of novel analytical tools to assess the enhancement of the antibody-dependent cellular cytoxicity response of an anticancer monoclonal antibody drug.

Commercialization

Sep 17, 2024

Development Strategies for Overcoming Commercialization Challenges

Coriolis Pharma’s Matthias Lucke, Ph.D., discusses how a seamless integration of services that accelerates drug development while mitigating risks associated with transitions between different development phases ensures a streamlined path to market.

Ophthalmology

Sep 16, 2024

The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success

Tracey Roberts, Jennifer Christiansen, Ph.D., and Debra Schaumberg, Sc.D., O.D., all with the PPD™ clinical research business of Thermo Fisher Scientific, discuss the growth and challenges of global, late-stage ophthalmology clinical trials and the key drivers of proactive planning for success.

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future

Cell Therapy

Sep 30, 2024

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future

In this Q&A, OrganaBio’s Chief Executive Officer Justin Irizarry discusses the strategies and operational philosophies driving the company and how it plans to navigate future challenges and opportunities in the rapidly evolving cell therapy landscape.

Gene Editing

Sep 30, 2024

MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing

Touchlight’s Elena Stoyanova, Ph.D., and Tom Adie, Ph.D., explain how the company’s new nonviral MegaBulb DNA (mbDNA) offers a high-purity, synthetic CRISPR ssDNA template that demonstrates remarkable efficiency and minimal toxicity.

Process Development

Sep 24, 2024

Economic Benefits of Digital Process Development

DataHow’s Fabian Feidl, Ph.D., discusses how advanced digital tools and strategies, including quality-by-design, hybrid modeling, transfer learning, and digital twins, not only enhance efficiency in process development but also substantially cut costs in manufacturing.

News

The Road to the Max: Australia

Top 5

dbDNA

Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA

Top 5

Digitalization

Aug 26, 2024

Radical Bioprocessing Efficiencies and Cost Reductions — The Next Wave of Biopharmaceutical Innovation

RoundTable

View all roundtable

RoundTable Topics

Milestones

What important company milestone do you anticipate reaching in 2022?

Alen Guy, Ph.D.

Anna Dormady

Dago Caceres

David W. Freidinger

Jeff Elton

In 2022, the Pharma Business group will be putting more choices, solutions, and resources directly in the hands of customers through an innovative approach to our website.

View all Answers

RoundTable

View all roundtable

Milestones

What important company milestone do you anticipate reaching in 2022?

Alen Guy, Ph.D.

Anna Dormady

Dago Caceres

David W. Freidinger

Jeff Elton

In 2022, the Pharma Business group will be putting more choices, solutions, and resources directly in the hands of customers through an innovative approach to our website.

View all Answers

RoundTable Topics

Milestones

Innovation

2021 Projections

Outsourcing Dynamics

Unmet medical needs

Therapeutic Areas

Investment Trends

Challenges

Predictions

Evolving Technologies

Digital Connections

Dealing with a Crisis

Lessons from the Pandemic

Social Media Marketing

U.S. Market

Post-COVID-19 Supply Chain

Virtual BD and Marketing

Global Access

Personalized and Precision Medicine

Leadership

Regulatory

Sustainability

Year in Review

Now Trending

Bioassays

Sep 30, 2024

Developing a Toolbox of Functional Bioassays for Optimizing ADCC

Transforming Precision Medicine through a High-Resolution Temporal Exposome Platform

Exposomics

Sep 05, 2024

Transforming Precision Medicine through a High-Resolution Temporal Exposome Platform

Process Development

Sep 24, 2024

Economic Benefits of Digital Process Development

Biopharma

Sep 27, 2024

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Cell Therapy

Sep 30, 2024

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future

Biotech

Sep 23, 2024

Five Small Biotechs to Watch: October 2024

Revolutionizing Biologics (and Biology) through a Focus on Women

Women's Health

Jul 09, 2024

Revolutionizing Biologics (and Biology) through a Focus on Women

Commercialization

Sep 17, 2024

Development Strategies for Overcoming Commercialization Challenges

Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform

Developability

Sep 04, 2024

Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform

Nanocarriers to Overcome the Blood–Brain Barrier (BBB)

Drug Delivery

Aug 30, 2024

Nanocarriers to Overcome the Blood–Brain Barrier (BBB)

Gene Editing

Sep 30, 2024

MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing

Transforming Drug Development through a Female Perspective

Female-Centric

Sep 10, 2024

Transforming Drug Development through a Female Perspective

RNA

Sep 30, 2024

Optimized Residual dsRNA Detection for mRNA Therapeutics

DoE for Clone Selection and Process Development to Meet Biosimilar Critical Qualities Attributes and High Productivity

Biosimilars

Sep 12, 2024

DoE for Clone Selection and Process Development to Meet Biosimilar Critical Qualities Attributes and High Productivity

Ophthalmology

Sep 16, 2024

The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success

Building on a Pioneering Biomanufacturing Legacy with Client Centricity

Expansion

Sep 09, 2024

Building on a Pioneering Biomanufacturing Legacy with Client Centricity

Videos

View all videos

Marketing

May 09, 2022

Transforming Market Insights into Growth

In another Road to 50 States interview, Pamela Roach, CEO at Breakthrough Marketing Technology, talks to Nigel about the company's mission and some of the key barriers that Breakthrough Marketing Technology are able to help their customers overcome.

Marketing

May 09, 2022

Transforming Market Insights into Growth

Stem Cell Therapy

Dec 12, 2023

Designing A Recipe for Stem Cell Therapy Success

Data Connectivity

Jan 19, 2022

Discussing the Advancements in Oncology

Failure to Launch

Aug 07, 2024

Disaster Strikes

Meet the Crew

Aug 07, 2024

Assembling the Crew

Supply Chain

Dec 12, 2023

Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience

Building Multiple Platforms to Address Difficult-to-Treat Cancers

Immuno-Oncology

May 24, 2022

Building Multiple Platforms to Address Difficult-to-Treat Cancers

The Power of Aqueous Detergents in Critical Cleaning

Aqueous Cleaning

Dec 05, 2023

The Power of Aqueous Detergents in Critical Cleaning

Setting Sail

Aug 07, 2024

Sailing into the Trade Winds

Preparing to Launch

Aug 07, 2024

Preparing the Yacht for the Race

Biologics CDMO

Jan 26, 2022

Growing as a Trusted, Dedicated Commercial Biologics CDMO

Decentralized Clinical Trials

Nov 17, 2022

The Evolving Role of Remote Monitoring

In Focus

Commercialization

Sep 17, 2024

Development Strategies for Overcoming Commercialization Challenges

Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform

Lipid Nanoparticles

Nov 01, 2023

Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform

Robotic Sterile Fill-Finish

Feb 14, 2024

Reducing Time to First-in-Human Trials with Robotic Sterile Fill-Finish Manufacturing Services

Developability

Aug 26, 2024

Assessing Developability and Designing Advanceable Formulations from the Start

Viscosity Reduction

Aug 10, 2023

Viscosity Reduction with An Excipient Platform and Feasibility Testing Service

Transforming Pharmaceutical Packaging with Sustainable, Cutting-Edge Solutions

Sustainable Packaging

Jul 02, 2024

Transforming Pharmaceutical Packaging with Sustainable, Cutting-Edge Solutions

Latest

View all latest

Areas of Interests

Academia CDMO Clinical CRO Drug Discovery Early R&D Excipients / Intermediates Financing Equipment Preclinical CRO Supply Chain Technology

A comprehensive market analysis with 110 major company profiles and detailed CDMO pricing information.

LEARN MORE

Over 60 company profiles covering the leading mRNA and LNP contract manufacturing organizations. Unique pricing comparison for the end-to-end manufacturing process.

LEARN MORE

Optimize your manufacturing process using 50+ established CDMO overviews and a requisite pricing study for small, mid sized and large manufacturers.

LEARN MORE

Comprehensive analysis of mammalian cell culture CDMOs including price benchmarking, market trends and over 80 company profiles.

LEARN MORE

Over 80 company profiles and analysis of leading microbial fermentation CDMO; exclusive market analysis and price comparison.

LEARN MORE

Understand the emerging ADC market with profiles on 30 notable CDMOs and an analysis of the value chain of mAbs, linkers and payloads. Benchmark with robust manufacturing pricing.

LEARN MORE

Exclusive pricing from 20+ CDMOs and market insight for pDNA as a reagent for advanced therapies and as a primary therapeutic.

LEARN MORE

Robust analysis of gene therapy market, includes 50 company profiles of AAV, Lentiviral and non-viral gene therapy CDMOs.

LEARN MORE

Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.

LEARN MORE

Over 80 extensive CDMO profiles for an all-encompassing benchmarking report. Exclusive pricing comparison and updated global GMP regulatory landscape

LEARN MORE

Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.

LEARN MORE

Roads to

Biopharma

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Fab Biopharma’s Reiner Getz, Ph.D., and Gardiner Smith, J.D. discuss how the company aims to revolutionize the treatment of complex and often life-threatening autoimmune diseases like Sjögren’s disease and lupus with its groundbreaking soluble bispecific receptor therapies

RNA

Optimized Residual dsRNA Detection for mRNA Therapeutics

A team of experts from Samsung Biologics discusses the company’s development of a superior ELISA-based method for dsRNA detection that ensures greater accuracy and reliability.

Bioassays

Developing a Toolbox of Functional Bioassays for Optimizing ADCC

Tanvex CDMO’s Anke Hartung, Ph.D., discusses her team’s development of novel analytical tools to assess the enhancement of the antibody-dependent cellular cytoxicity response of an anticancer monoclonal antibody drug.

Commercialization

Development Strategies for Overcoming Commercialization Challenges

Coriolis Pharma’s Matthias Lucke, Ph.D., discusses how a seamless integration of services that accelerates drug development while mitigating risks associated with transitions between different development phases ensures a streamlined path to market.

Ophthalmology

The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success

Tracey Roberts, Jennifer Christiansen, Ph.D., and Debra Schaumberg, Sc.D., O.D., all with the PPD™ clinical research business of Thermo Fisher Scientific, discuss the growth and challenges of global, late-stage ophthalmology clinical trials and the key drivers of proactive planning for success.

Cell Therapy

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future

In this Q&A, OrganaBio’s Chief Executive Officer Justin Irizarry discusses the strategies and operational philosophies driving the company and how it plans to navigate future challenges and opportunities in the rapidly evolving cell therapy landscape.

Gene Editing

MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing

Touchlight’s Elena Stoyanova, Ph.D., and Tom Adie, Ph.D., explain how the company’s new nonviral MegaBulb DNA (mbDNA) offers a high-purity, synthetic CRISPR ssDNA template that demonstrates remarkable efficiency and minimal toxicity.

Process Development

Economic Benefits of Digital Process Development

DataHow’s Fabian Feidl, Ph.D., discusses how advanced digital tools and strategies, including quality-by-design, hybrid modeling, transfer learning, and digital twins, not only enhance efficiency in process development but also substantially cut costs in manufacturing.

Most Read

Biosimilars

Synthetic DNA

RNA

News

The Road to the Max: Australia

The Road to the Max: Australia

Editor's Pick

Cell and Gene Therapy

AAV

RNA

dbDNA

Synthetic DNA

Exosomes

Cell Therapy

Lipid Nanoparticles

Gene Editing

Top 5

dbDNA

Top 5

Digitalization

RoundTable

RoundTable

Now Trending

Bioassays

Exposomics

Process Development

Biopharma

Cell Therapy

Biotech

Women's Health

Commercialization

Developability

Drug Delivery

Gene Editing

Female-Centric

RNA

Biosimilars

Ophthalmology

Expansion

Videos

Marketing

In another Road to 50 States interview, Pamela Roach, CEO at Breakthrough Marketing Technology, talks to Nigel about the company's mission and some of the key barriers that Breakthrough Marketing Technology are able to help their customers overcome.

Marketing

Stem Cell Therapy

Data Connectivity

Failure to Launch

Meet the Crew

Supply Chain

Immuno-Oncology

Aqueous Cleaning

Setting Sail

Preparing to Launch

Biologics CDMO

Decentralized Clinical Trials

In Focus